RECRUITINGINTERVENTIONAL
Testing the Efficacy of 100mg Vitamin-B6 Daily for Sensory Reactivity in Autism
Testing the Potential of High-dose Vitamin B6 Supplements for Sensory Reactivity in Autism
About This Trial
This clinical trial aims to explore the effect of Vitamin B6 supplementation on anxiety sensory hyperreactivity in autistic adults. Researchers will compare a placebo group to high-dose Vitamin-B6 to see if vitamin B6 reduce anxiety and sensory reactivity differences in autism.
Who May Be Eligible (Plain English)
Who May Qualify:
- Between the ages of 18 to 60
- With a diagnosis of autism
Who Should NOT Join This Trial:
- Taking any supplement that contains more than 2mg of Vitamin B6 or taking GABA agonist drugs
- Have a medical history of peripheral neuropathy
- lactose intolerance (placebo tablet is lactose based)
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Between the ages of 18 to 60
* With a diagnosis of autism
Exclusion Criteria:
* Taking any supplement that contains more than 2mg of Vitamin B6 or taking GABA agonist drugs
* Have a medical history of peripheral neuropathy
* lactose intolerance (placebo tablet is lactose based)
Treatments Being Tested
DIETARY_SUPPLEMENT
Pyridoxal 5'-Phosphate (100 mg)
100 mg Pyridoxal 5'-Phosphate tablet once daily with food
OTHER
Placebo
Placebo tablet once daily
Locations (1)
University of Reading
Reading, United Kingdom